Cameco Q2 Earnings Miss and Valuation Pressures Trigger Downgrade
Cameco’s second-quarter results fell short of consensus expectations, with revenue and EPS both below analyst forecasts. This performance coincides with a fresh sell rating from Wall Street Zen, citing high valuation metrics despite a broader market consensus of moderate buy.
Cameco Corporation closed trading at USD 91.62 on the New York Stock Exchange on September 18, 2026, a level that sits 32.2 percent below its 52-week high of USD 135.24. The uranium producer reported second-quarter results for the period ended June 30, 2026, that revealed a significant performance gap against market expectations. Revenue totaled USD 573.06 million, marking a 6.8 percent decline year-over-year and falling short of the USD 579.60 million consensus estimate. Earnings per share came in at USD 0.13, missing the expected USD 0.26 by 50 percent, whereas the comparable quarter in the prior year yielded USD 0.71 per share.
These operational figures underscore a business profile that remains profitable but faces margin compression, with a reported net margin of 10.20 percent and a return on equity of 7.59 percent. The stock’s recent trajectory reflects broader sector adjustments, as Cameco shares declined 2.92 percent over the previous month. This underperformance contrasts with the Oils-Energy sector, which gained 1.36 percent during the same period, and the S&P 500, which fell 1.29 percent. As of the latest data, the company holds a market capitalization of approximately USD 39.91 billion, with a trailing price-to-earnings ratio of 157.74, a multiple that has drawn scrutiny from valuation-focused investors.
Analyst Ratings Split on Valuation
Wall Street Zen recently downgraded Cameco from hold to sell, citing concerns over the company’s rich price-to-earnings multiple. This bearish shift contrasts with the broader analyst community, which maintains a constructive outlook. According to MarketBeat, eighteen analysts covering the stock have assigned five hold ratings and thirteen buy ratings, resulting in an aggregate consensus of Moderate Buy. The median 12-month price target stands at USD 148.68, implying potential upside of roughly 62 percent from the September 18 closing price, assuming forecasts are realized.
Jefferies Financial Group has also entered the coverage universe, initiating a buy rating with a price target of USD 138.00. This divergence in opinion highlights the debate surrounding Cameco’s valuation relative to its earnings trajectory. While some analysts view the current multiple as excessive given the recent earnings miss, others see the forward-looking metrics as supportive. The forward price-to-earnings ratio is listed at 72.96, with a PEG ratio of 1.59, suggesting that growth expectations remain a central pillar of the investment thesis despite the short-term setbacks.
Forward Earnings Expectations Remain High
Looking beyond the immediate quarterly results, research analysts tracked in recent overviews expect Cameco to post earnings per share of USD 1.27 for the current fiscal year. This projection implies a substantial improvement relative to the latest quarterly run rate, reflecting confidence in the long-term nuclear demand cycle. The company’s strategic position in uranium production continues to be a key driver of interest, even as near-term financial metrics experience volatility. Investors are now watching how the company manages its cost structure and production volumes to bridge the gap between current performance and these elevated forward estimates.
